These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38995799)

  • 41. The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.
    Ribarič S
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein.
    Vicente Miranda H; Chegão A; Oliveira MS; Fernandes Gomes B; Enguita FJ; Outeiro TF
    FASEB J; 2020 May; 34(5):6718-6728. PubMed ID: 32259355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.
    Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF
    PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
    Olsen AL; Feany MB
    Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
    Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
    Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ferroptosis-A Shared Mechanism for Parkinson's Disease and Type 2 Diabetes.
    Duță C; Muscurel C; Dogaru CB; Stoian I
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains.
    Zucchelli S; Codrich M; Marcuzzi F; Pinto M; Vilotti S; Biagioli M; Ferrer I; Gustincich S
    Hum Mol Genet; 2010 Oct; 19(19):3759-70. PubMed ID: 20634198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin role in Parkinson's disease: a double-sword effect.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Ashour NA; Jabir MS; Negm WA; Batiha GE
    Mol Cell Biochem; 2024 Apr; 479(4):975-991. PubMed ID: 37266747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.
    Cole TA; Zhao H; Collier TJ; Sandoval I; Sortwell CE; Steece-Collier K; Daley BF; Booms A; Lipton J; Welch M; Berman M; Jandreski L; Graham D; Weihofen A; Celano S; Schulz E; Cole-Strauss A; Luna E; Quach D; Mohan A; Bennett CF; Swayze EE; Kordasiewicz HB; Luk KC; Paumier KL
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
    Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?
    Outeiro TF; Harvey K; Dominguez-Meijide A; Gerhardt E
    Biochem Soc Trans; 2019 Jun; 47(3):827-838. PubMed ID: 31085616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
    Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
    J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential.
    Brahmachari S; Karuppagounder SS; Ge P; Lee S; Dawson VL; Dawson TM; Ko HS
    J Parkinsons Dis; 2017; 7(4):589-601. PubMed ID: 29103051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy.
    Flores-Leon M; Outeiro TF
    Acta Neuropathol; 2023 Sep; 146(3):369-385. PubMed ID: 37421475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long Non-coding RNAs in Parkinson's Disease.
    Xin C; Liu J
    Neurochem Res; 2021 May; 46(5):1031-1042. PubMed ID: 33544326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
    Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
    Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.
    Sian-Hulsmann J; Riederer P
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson's Disease and Related Diseases.
    Sun Y; Guo C; Yuan L; Li W; Wang ZY; Yue F; Li JY
    Front Neurosci; 2020; 14():63. PubMed ID: 32116510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications.
    Hassan A; Sharma Kandel R; Mishra R; Gautam J; Alaref A; Jahan N
    Cureus; 2020 Aug; 12(8):e9853. PubMed ID: 32832307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.